← All diseases
Liver, kidneys and digestion
Primary sclerosing cholangitis
Would you like to receive a message when there is new research on Primary sclerosing cholangitis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication you'll see one sentence explaining what was investigated — and you'll get notified as soon as there is new research on Primary sclerosing cholangitis. View what Premium costs.
Publications and studies (1452)
- Genetic link between primary sclerosing cholangitis and thyroid dysfunction: a bidirectional two-sample Mendelian randomization study. (2023/10/19) ♡
- IL-17 Signaling in Primary Sclerosing Cholangitis Patient-Derived Organoids. (2023/10/16) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. LIVER TRANSPLANTATION IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS: A MULTICENTRIC STUDY. (2023/10/13) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma: From Pathogenesis to Diagnostic and Surveillance Strategies. (2023/10/11) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Farnesoid X Receptor Agonists: A Promising Therapeutic Strategy for Gastrointestinal Diseases. (2023/10/06) ♡
- Low prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease in India. (2023/10/01) ♡
- Clinical and biochemical impact of vitamin B6 deficiency in primary sclerosing cholangitis before and after liver transplantation. (2023/10/01) ♡
- Polygenic risk score predicts risk of primary sclerosing cholangitis in inflammatory bowel disease. (2023/10/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Mucosa-associated microbiota alterations in primary sclerosing cholangitis (PSC) before and after liver transplantation-who is calling the shots? (2023/10/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Regional variations in the prevalence of primary sclerosing cholangitis associated with inflammatory bowel disease. (2023/10/01) ♡
- Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)-A European Society of Organ Transplantation (ESOT) Consensus Statement. (2023/09/29) ♡
- Liver transplant in patients with primary sclerosing cholangitis: A retrospective cohort from Northeastern Brazil. (2023/09/27) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Noninvasive prognostic models, imaging, and elastography to predict clinical events in primary sclerosing cholangitis: A review. (2023/09/27) ♡
- Association between Gastric Cancer and 12 Autoimmune Diseases: A Mendelian Randomization Study. (2023/09/23) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. PheWAS and cross-disorder analysis reveal genetic architecture, pleiotropic loci and phenotypic correlations across 11 autoimmune disorders. (2023/09/21) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Association of ulcerative colitis, celiac disease, primary sclerosing cholangitis and liver cirrhosis in a young male. (2023/09/19) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Previously Untreated Ulcerative Colitis With Newly Diagnosed Primary Sclerosing Cholangitis: A Case Report. (2023/09/15) ♡
- Primary sclerosing cholangitis hospitalizations in the United States: characteristics and predictors of clinical outcomes. (2023/09/14) ♡
- Predictors of clinical outcomes of hospitalized patients with primary sclerosing cholangitis in the United States. (2023/09/13) ♡
- Update on the optimisation of endoscopic retrograde cholangiography (ERC) in patients with primary sclerosing cholangitis. (2023/09/12) ♡
- Biliary disease progression in childhood onset autoimmune liver disease: A 30-year follow-up into adulthood. (2023/09/09) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. The Time is Ripe for a Randomized Controlled Trial of Oral Vancomycin in Primary Sclerosing Cholangitis. (2023/09/01) ♡
- Novel Genetic Risk Variants and Clinical Predictors Associated With Primary Sclerosing Cholangitis in Patients With Ulcerative Colitis. (2023/09/01) ♡
- Epidemiology, clinical features and management of autoimmune hepatitis in Switzerland: a retrospective and prospective cohort study. (2023/08/31) ♡
- Accuracy of controlled attenuation parameter measurement for the detection of steatosis in autoimmune liver diseases. (2023/08/29) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Non-steroidal FXR agonist cilofexor improves cholestatic liver injury in the Mdr2(-/-) mouse model of sclerosing cholangitis. (2023/08/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Primary sclerosing cholangitis and overlap features of autoimmune hepatitis: A coming of age or an age-ist problem? (2023/08/01) ♡
- Patient-reported quality of care in primary sclerosing cholangitis. (2023/08/01) ♡
- JNKs protect from cholestatic liver disease progression by modulating Apelin signalling. (2023/07/18) ♡
- Endoscopic Surveillance for Colorectal Cancer in Pediatric Ulcerative Colitis: A Survey Among Dutch Pediatric Gastroenterologists. (2023/07/17) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Pediatric Autoimmune or Primary Sclerosing Cholangitis: Metronidazole Effectiveness on Biochemical Data, Bile Acid Profile, and Gut Microbiota: A Pilot Study. (2023/07/17) ♡
- Bile proteome analysis by high-precision mass spectrometry to examine novel biomarkers of primary sclerosing cholangitis. (2023/07/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Early diagnosis of ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis syndrome: A case report. (2023/07/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. An unusual cause of extrahepatic cholestasis associated with solid liver lesions: a case report. (2023/07/01) ♡
- CrebH protects against liver injury associated with colonic inflammation via modulation of exosomal miRNA. (2023/06/27) ♡
- Cholangiocarcinoma cell proliferation is enhanced in primary sclerosing cholangitis: A role for IL-17A. (2023/06/15) ♡
- Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis. (2023/06/06) ♡
- The differences in post-liver transplant outcomes of patients with autoimmune hepatitis who present with overlapping autoimmune liver diseases. (2023/06/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Letter to the Editor: Insurance should cover vancomycin for primary sclerosing cholangitis. (2023/06/01) ♡
- Prolonged administration of a secretin receptor antagonist inhibits biliary senescence and liver fibrosis in Mdr2 -/- mice. (2023/06/01) ♡
- Longitudinal changes in quantitative magnetic resonance imaging metrics in children and young adults with autoimmune liver disease. (2023/06/01) ♡
- DCDC2-Related Ciliopathy: Report of Six Polish Patients, Novel DCDC2 Variant, and Literature Review of Reported Cases. (2023/05/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Post-COVID-19 Cholangiopathy: A Systematic Review. (2023/05/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Optimal timing of liver transplantation for liver cirrhosis caused by sclerosing cholangitis in a patient with Langerhans cell histiocytosis: a case report. (2023/05/01) ♡
- [IgG4-associated cholangitis]. (2023/05/01) ♡
- Primary sclerosing cholangitis with partial steroid responsiveness: a case report. (2023/05/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Bile acid-mediated signaling in cholestatic liver diseases. (2023/04/29) ♡
- Living-Donor Liver Transplant and Improved Post-Transplant Survival in Patients with Primary Sclerosing Cholangitis. (2023/04/11) ♡
- Good outcomes of living donor liver transplant in primary sclerosing cholangitis: an experience from North India. (2023/04/01) ♡
- Risks of colorectal cancer and biliary cancer according to accompanied primary sclerosing cholangitis in Korean patients with ulcerative colitis: a nationwide population-based study. (2023/04/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.